TransCode Therapeutics, Inc. (NASDAQ: RNAZ) a clinical stage company pioneering immuno-oncology and RNA for the treatment of ...
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced Wednesday that it has successfully completed the Phase 1a ...
TransCode Therapeutics, Inc. a annoncé de nouveaux résultats concernant son essai clinique d'escalade de dose de phase 1a. L'étude a atteint son critère d'évaluation principal en matière ...
TransCode Therapeutics, Inc. a annoncé le lancement de son essai clinique de phase 2a. Cette étude vise à évaluer le principal candidat thérapeutique de la société, le TTX-MC138, chez ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of ...
BOSTON, May 27, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today ...
NASA Goddard Space Flight Center's Dr. Jennifer Wiseman explains the Hubble Space Telescope's view of the Pillars of Creation ...
NASA Goddard Space Flight Center's Dr. Jennifer Wiseman explains the Hubble Space Telescope's view of the Pillars of Creation ...
The chief exec talked with Fast Company about visual data as the enterprise’s most neglected infrastructure problem, and why ...
I immediately changed these four Plex settings, and my personal media server setup is all the better for it.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Detailed price information for Transcode Therapeutics Inc (RNAZ-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results